PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.
Clinical trial NCT06807736 · RECRUITING
Trial details
- NCT number
- NCT06807736
- Sponsor
- Desmond Tutu HIV Foundation
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-13
- Primary completion
- 2025-12-31
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.